Stay updated on Pediatric Galcanezumab for Episodic Migraine Clinical Trial
Sign up to get notified when there's something new on the Pediatric Galcanezumab for Episodic Migraine Clinical Trial page.

Latest updates to the Pediatric Galcanezumab for Episodic Migraine Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe footer now identifies the site as revision v3.8.0 instead of v3.7.2.SummaryDifference0.0%

- Check22 days agoChange DetectedA sitewide NIH banner announces a transition in terminology, stating that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference0.2%

- Check29 days agoChange DetectedThe website footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.0%

- Check36 days agoChange DetectedThe ClinicalTrials.gov site footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page footer's Revision label updates from v3.6.6 to v3.7.0, indicating a new site version for the Study Record History page.SummaryDifference0.0%

- Check77 days agoChange DetectedA new Revision: v3.6.6 appears in the history. The previous Revision: v3.6.5 is removed.SummaryDifference0.0%

Stay in the know with updates to Pediatric Galcanezumab for Episodic Migraine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Galcanezumab for Episodic Migraine Clinical Trial page.